Arne N. Akbar

Line L. Holm^1,2,3, 

Milica Vukmanovic-Stejic⁴, 

Thomas Blauenfeldt¹, 

Thomas Benfield^2,3, 

Peter Andersen¹, 

Arne N. Akbar⁴, 

Morten Ruhwald¹ 

¹Department of Infectious Disease Immunology, Center for Vaccine Research, Statens Serum Institut, 

²Department of Infectious Diseases, Hvidovre Hospital, 

³Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 

⁴Division of Infection and Immunity, University College London